HR 6320119th CongressIn Committee
Improving Medicaid Precision and Cancer Test Act of 2025
Standard Summary
Balanced plain-English summary
This bill amends Medicaid law to require state Medicaid programs to cover lung cancer biomarker testing, adding it to mandatory benefits and managed care coverage beginning January 1, 2027. It is intended to improve access to precision cancer testing for Medicaid beneficiaries.
Key Points
- 1Requires Medicaid coverage of lung cancer biomarker testing.
- 2Adds the testing to mandatory Medicaid benefits under title XIX.
- 3Requires coverage in Medicaid managed care beginning January 1, 2027.
- 4Applies to state Medicaid programs starting January 1, 2027.
Impact Areas
Medicaid beneficiariesCancer patientsState Medicaid programsHealthcare providersManaged care organizations
Generated by deepseek/deepseek-v4.1-flash-1017Nov 18, 2026